Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,459 INR | -1.34% | -2.41% | +15.85% |
May. 27 | Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research | RE |
May. 25 | Sun Pharma to Pursue M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.85% | 42.57B | |
+18.28% | 21.01B | |
+16.56% | 14.86B | |
+17.68% | 14.47B | |
+48.57% | 12.61B | |
-0.05% | 6.79B | |
-12.56% | 6.57B | |
+14.28% | 5.62B | |
+6.11% | 4.66B | |
+15.91% | 4.25B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Jefferies Adjusts Sun Pharmaceutical Industries’ Price Target to INR1,310 From INR1,150, Keeps at Buy